Navigation Links
PharmAthene to Provide Update on SparVax(TM) Contract Modification Suspension During Year-End 2009 Financial and Operational Results Conference Call on Tuesday March 23, 2010
Date:3/22/2010

2';s.tl(this,'o','ExternalLink');" target='_blank' href="http://www.pharmathene.com/">www.pharmathene.com.  A link to the webcast may be found under the Investor Relations section of the website.

About PharmAthene, Inc.

PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead product development programs include:

  • SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine
  • Third generation rPA anthrax vaccine
  • Valortim(R) - a fully human monoclonal antibody for the prevention and treatment of anthrax infection
  • Protexia(R) - a novel bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents

For more information about PharmAthene, please visit

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010
2. PharmAthene to Present at the 2010 Roth Capital Markets Growth Stock Conference on Monday, March 15, 2010
3. PharmAthene Submits White Paper to BARDA for Advanced Development Funding for SparVax(TM) - Novel Recombinant Protective Antigen Anthrax Vaccine
4. PharmAthene Appoints Jeffrey W. Runge, M.D. to the Companys Board of Directors
5. PharmAthene Announces Updated Time for Conference Call to Review BARDA rPA Decision
6. PharmAthene Reports Third Quarter 2009 Financial and Operational Results
7. PharmAthene Executives Featured in Anthrax Pathogen Training Video for U.S. Department of Homeland Security
8. PharmAthene Presents Data for Valortim(R) Anthrax Anti-Toxin and Third Generation rPA Anthrax Vaccine Programs at the Bacillus - ACT 2009 Conference
9. PharmAthene to Present at the Rodman and Renshaw Annual Global Investment Conference September 10, 2009
10. PharmAthene Reports Second Quarter 2009 Financial and Operational Results
11. PharmAthene to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... German . ... have demonstrated a new kind of building block for ... chips could be based on three-dimensional arrangements of nanometer-scale ... of the semiconductor industry CMOS fabrication of silicon ... collaborators at the University of Notre Dame are exploring ...
(Date:9/30/2014)... , Sept. 30, 2014 Nematicide is ... nematodes. Nematodes are microscopic parasitic roundworms, found in ... inside other plants and animals. Nematicides have tended ... other properties promoting migration through the soil. A ... 1,000 plant-parasitic nematodes. With more than 10,000 species ...
(Date:9/30/2014)... , Sept. 30, 2014 CORD:USE Cord Blood ... announce that it has entered into an Equity and ... which has licensed a series of patented technologies for the ... possible clinical applications.  Tianhe is performing Phase I/II clinical ... Spain using Tianhe,s Stem Cell Educator ...
(Date:9/30/2014)... BioHealth Innovation, Inc. (BHI), a ... and increasing access to early-stage funding in ... Tania Fernandez , Ph.D., has joined the BHI ... a member of the management team for a new ... million in seed and early-stage equity investments to therapeutics, ...
Breaking Biology Technology:A new dimension for integrated circuits: 3-D nanomagnetic logic 2A new dimension for integrated circuits: 3-D nanomagnetic logic 3Nematicides Market by Types (Fumigants, Organophosphates, Carbamate and Bio-Nematicides), Applications (Agrochemicals, Industrial, and Others), and Geography (North America, Europe, Asia-Pacific & ROW) - Global Trends & Forecasts to 2019 2CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 2CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 3CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 4Seasoned Life Sciences Venture Capitalist Tania Fernandez Joins BHI to Help Manage New BioHealth Gap Fund 2
... April 13, 2011 Today Massachusetts Life Sciences Center ... officials,  Organogenesis, Inc. President & CEO Geoff MacKay and ... Dan Road.  Upon completion in 2013, the company expects ... cell manufacturing plant.   Organogenesis is in ...
... Biosciences, a global manufacturer of products designed to ... labor intensive, today announced an agreement with Bruker ... microbial identification from cultures using MALDI-TOF proteomic finger-printing, ... research, and veterinary laboratory customers. The compatible product ...
... published in the March 14 edition of the ... and testing of a new type solar cell using ... nanowires (described has "quantum coaxial cables") had previously been ... chemically more stable large bandgap inorganic materials, should also ...
Cached Biology Technology:Organogenesis, Life Sciences Center Break Ground on World's Largest Automated Living Cell Manufacturing Plant 2Organogenesis, Life Sciences Center Break Ground on World's Largest Automated Living Cell Manufacturing Plant 3Organogenesis, Life Sciences Center Break Ground on World's Largest Automated Living Cell Manufacturing Plant 4Magellan Biosciences Announces Agreement with Bruker to Provide Microbiology Tools to Battle Drug Resistance 2Magellan Biosciences Announces Agreement with Bruker to Provide Microbiology Tools to Battle Drug Resistance 3Magellan Biosciences Announces Agreement with Bruker to Provide Microbiology Tools to Battle Drug Resistance 4Device proves solar cell potential of high bandgap inorganic nanowire arrays 2Device proves solar cell potential of high bandgap inorganic nanowire arrays 3
(Date:9/30/2014)... all have in common? Unlike most eukaryotic multicellular ... diploid, these organisms are all polyploid, meaning they have ... have 3 and 4 sets of chromosomes, respectively, and ... in fact most plant species are polyploid. Polyploidy, or ... but only recently, with the development of molecular tools, ...
(Date:9/30/2014)... professor and Howard Hughes Medical Institute investigator, and ... recipients in the 2014 round of grants from ... BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative ... September 30, provides more than $3 million in ... , The BRAIN Initiative, launched last year, is ...
(Date:9/30/2014)... of Medicine reports positive results of a phase ... subset of lung cancer marked by rearrangement of the ... with advanced non-small cell lung cancer testing positive for ... with 3 complete responses and 33 partial responses. Median ... disease to resume its growth after being slowed by ...
Breaking Biology News(10 mins):Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 2Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 3Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 4Salk scientists receive $3 million for BRAIN Initiative grant 2NEJM: Crizotinib effective in Phase 1 trial against ROS1 lung cancer 2
... bites, and business struggle to stay primed, researchers in ... and business practice is needed if a company is ... Practice from Inderscience Publishers, the team explains how businesses ... Palmira Lpez-Fresno of "STIGA" in Barcelona is working ...
... An undergraduate student at Rensselaer Polytechnic Institute has learned ... help the medicine go down. In fact, with his ... Among the most important and complex molecules in the ... how cells communicate with one another. Graduating senior Jeffery ...
... discovery of the duck-billed, egg-laying, otter-footed, beaver-tailed, venomous platypus ... must be a hoax. Sketches of its appearance were ... that the oddness of the platypus, looks isn,t just ... avian, reptilian and mammalian lineages that may hold clues ...
Cached Biology News:Programmed death boosts business 2Undergrad has sweet success with invention of artificial Golgi 2Undergrad has sweet success with invention of artificial Golgi 3Platypus genome decoded 2Platypus genome decoded 3
... N,N- bis- (3-D-Gluconamidopropyl)deoxycholamide White ... CHAPS and CHAPSO. Has reduced electrostatic interactions ... chromatography on DEAE-cellulose. Aggregation number: 8-16. ... H 2 O. Aggregation number 8 - ...
... 2000 Pipette is a synonym for pipetting ... robust design, and superior operating comfort. Its ... the measuring stroke and blow-out as well ... system ensures utmost accuracy and precision. Ejection ...
... This protein is a member of the ... Members of the PAX family typically contain ... homeodomain. These proteins play critical roles during ... 3 are associated with Waardenburg syndrome, craniofacial-deafness-hand ...
Compact, portable device, seals 96 and 384 well plates with preset temperature optimised for Eppendorf heat sealing foils and films. Suitable for plates of different heights. AC input: 50/60 Hz230 V...
Biology Products: